Latest Shareholder Approval News

Brickworks Limited and Washington H. Soul Pattinson have unveiled plans to combine under a newly capitalised ASX-listed entity, Topco, aiming to simplify their complex cross-shareholding and unlock shareholder value. Shareholders are set to vote on the scheme in September, with the merger expected to enhance liquidity and deliver dividend accretion.

Adherium Limited has raised A$0.35 million through an institutional placement, supplementing its recent entitlement offer to strengthen its financial position and support growth initiatives.

Papyrus Australia Ltd has announced a $262,000 capital raise through a share placement and unlisted options, aiming to strengthen its working capital and research efforts.

Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.

Enova Mining has raised $0.85 million to fund a diamond drilling campaign targeting high-grade rare earth elements at its East Salinas Project in Brazil, signaling strong investor confidence and advancing its critical minerals portfolio.

Stavely Minerals has raised A$1.9 million through a placement to fund drilling at its promising gold prospects, including Fairview North and South. The move aims to accelerate exploration and deliver new insights later this year.

ActivePort Group Ltd has announced a fully underwritten entitlement offer to raise approximately $2.5 million, issuing new shares and options to existing shareholders and underwriters. The capital raise aims to fund business growth and repay loans but will dilute non-participating shareholders significantly.

Domain Holdings Australia announces a special fully franked dividend of 8.8 cents per share, contingent on shareholder and court approval of its acquisition by CoStar Group.

Domain Holdings Australia has announced a fully franked special dividend alongside a recommended $4.43 per share acquisition offer from CoStar Group, pending shareholder and court approval.

Nyrada Inc. has raised $8.25 million through a strategic placement to fund its upcoming Phase IIa clinical trial of Xolatryp for acute myocardial infarction, positioning the company for a pivotal year ahead.

Loyal Metals has raised $2 million through a targeted placement to accelerate exploration at its newly acquired Highway Reward Copper-Gold Mine, leveraging cutting-edge AI and drone technologies.

Heavy Rare Earths Limited (ASX – HRE) has struck a binding agreement to acquire an 80% interest in the Prospect Hill tin project, South Australia’s largest and most advanced tin deposit, expanding its footprint in critical minerals.